Six months represents the minimum for meaningful results, but 12 months or longer produces significantly better outcomes
Combination treatment is not required for every patient and should be individualized
The most common retatrutide side effects are nausea (28%), diarrhea (24%), constipation (21%), and vomiting (17%), with symptoms peaking around weeks 6-8 before substantially improving by week 12
The best place to inject semaglutide GLP-1 is typically in the fatty tissue just under the skin, also known as the subcutaneous tissue
GLP-1 injections are backed by extensive clinical research, regulated by the MHRA, and prescribed and monitored by healthcare professionals
Added check-ins for accountability Dosing adjusted to your response Structured plan to stay on track Complete intake and provider review